Stockreport

Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients [Read more]